Polymorphisms in voltage-gated sodium channel alpha 1-subunit as markers for therapy selection

作者: Heinz-Josef Lenz

DOI:

关键词:

摘要: A method for determining whether a patient in need thereof will respond to chemotherapy by screening suitable sample isolated from the pre-selected polymorphism present VGSC gene.

参考文章(48)
Survival after postoperative combination treatment of rectal cancer. The New England Journal of Medicine. ,vol. 315, pp. 1294- 1295 ,(1986) , 10.1056/NEJM198611133152014
J. Yun, W. Zhang, D. Park, D. Yang, O. Press, M. Gordon, N. Mallik, H. J. Lenz, Molecular profiling predicts clinical outcome in patients with metastatic colorectal cancer treated with 5-FU/oxaliplatin Journal of Clinical Oncology. ,vol. 22, pp. 3519- 3519 ,(2004) , 10.1200/JCO.2004.22.90140.3519
Bert Vogelstein, David Sidransky, Ruth W. Craig, Michael B. Kastan, Onyinye Onyekwere, Participation of p53 Protein in the Cellular Response to DNA Damage Cancer Research. ,vol. 51, pp. 6304- 6311 ,(1991)
Arnold J. Levine, The p53 tumor-suppressor gene. The New England Journal of Medicine. ,vol. 326, pp. 1350- 1352 ,(1992) , 10.1056/NEJM199205143262008
Syma Iqbal, Heinz-Josef Lenz, Individualized chemotherapy based on genetic and genomic profiling Current Colorectal Cancer Reports. ,vol. 1, pp. 91- 102 ,(2005) , 10.1007/S11888-005-0005-4
Li Yan, Robert A. Beckman, Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development BioTechniques. ,vol. 39, pp. 565- 568 ,(2005) , 10.2144/000112043
Helmuth Adelsberger, Stefan Quasthoff, Julian Grosskreutz, Alexandra Lepier, Florian Eckel, Christian Lersch, The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons European Journal of Pharmacology. ,vol. 406, pp. 25- 32 ,(2000) , 10.1016/S0014-2999(00)00667-1